Andrew S. Ishizuka
Boston Children's Hospital(US)National Institutes of Health(US)University of Oxford(GB)Integrated BioTherapeutics (United States)(US)National Institute of Allergy and Infectious Diseases(US)Jenner Institute(GB)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Malaria Research and Control, Mosquito-borne diseases and control, vaccines and immunoinformatics approaches, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity(2015)432 cited
- → Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization(2016)419 cited
- → Sterile protection against human malaria by chemoattenuated PfSPZ vaccine(2017)408 cited
- → Protection against malaria at 1 year and immune correlates following PfSPZ vaccination(2016)374 cited
- → Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens(2020)327 cited
- → Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection(2017)251 cited